CClinicalTrials.gg
RecruitingNCT07008781Updated Apr 28, 2026

A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening

An interventional study of Youth-led cancer screening intervention in Cancer, sponsored by Rutgers, The State University of New Jersey. Recruiting at 1 site in United States. Open to participants aged 15 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by Rutgers, The State University of New Jersey · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started May 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Not applicable
Ages
15 Years to 80 Years
Sex
All
01

Study summary

This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening.

02

Conditions studied

  • Cancer

Browse trials for

Keywords

  • cancer screening
  • adolescents
  • high school
  • community-based research
  • community health
  • Hispanic/Latino community
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,486 are open to participants now.

This study's planned enrollment of 84 is above the median of 50 across 7,250 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Rutgers, The State University of New Jersey is the lead sponsor of 496 studies on the registry; 130 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 30 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Student at New Brunswick Health Sciences Technology High School (15-18 years) and their adult family members (18+ years old) who are NJ residents.
  • Adults must be eligible for at least one cancer screening other than skin (see below).
  • Participants must be fluent in either English or Spanish and the youth must speak the same language as the adult.

Breast: 40-74 year old women Cervical: 21-65 year old women with a cervix (have not had a hysterectomy) Colorectal: 45-75 year olds Prostate: 50 to 69 year old men (start at 45 for black males) Lung: 50 to 80 year olds who currently smoke or quit within the past 15 years

Overall:

21-75 year old women 45-75 year old men 76-80 year olds who currently smoke or quit within the past 15 years

Exclusion criteria

Exclusion Criteria:

  • Students less than 15 years old.
  • Adults not eligible for a cancer screening of interest.
  • Unable to speak fluent English or Spanish.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Youth-led cancer screening intervention

    High school students will be trained as health advocates and then facilitate discussions about cancer screening recommendations and risk factors with adults in their community. High school students (15-18 years old) from the local community will be recruited for this study, and each student will recruit adults that they live with or are part of their community (i.e. parent) who are eligible for cancer screening. The adult plus youth dyads will all undergo the same youth-led intervention in which the youth will utilize motivational interviewing to discuss cancer screening recommendations and risk factors with their adults and help their adults enroll in cancer screening through ScreenNJ, a community organization that aims to increase cancer screening in New Jersey, reduce cancer mortality rates, and reduce disparities.

    Behavioral: Youth-led cancer screening intervention

Interventions

  • BehavioralYouth-led cancer screening intervention

    High school students will be trained as health advocates and then facilitate discussions about cancer screening recommendations and risk factors with adults in their community. High school students (15-18 years old) from the local community will be recruited for this study, and each student will recruit adults that they live with or are part of their community (i.e. parent) who are eligible for cancer screening. The adult plus youth dyads will all undergo the same youth-led intervention in which the youth will utilize motivational interviewing to discuss cancer screening recommendations and risk factors with their adults and help their adults enroll in cancer screening through ScreenNJ, a community organization that aims to increase cancer screening in New Jersey, reduce cancer mortality rates, and reduce disparities.

06

What researchers measure

Primary outcomes

  1. Rate of Cancer Screening

    % of adults who schedule or conduct cancer screening 2 weeks post-intervention

    Time frame: 2 weeks post-intervention

Secondary outcomes

  1. Change in Cancer Screening Knowledge- Adult

    Change in Pre-/post-cancer screening knowledge in the adult using a 7-item assessment that the study team created. Higher scores indicate more knowledge.

    Time frame: Baseline and 3 days later

  2. Change in Cancer Screening Knowledge- Youth

    Change in Pre-/post-cancer screening knowledge in the youth using a 7-item assessment that the study team created. Higher scores indicate more knowledge.

    Time frame: Baseline and after intervention ends

  3. Change in Youth Self-Efficacy

    Change in Pre-/post youth self-efficacy using a 10-item assessment that the study team created and includes some questions adapted from Patient Activation Measure (PAM-10). Higher scores indicate more self-efficacy.

    Time frame: Baseline and after intervention ends

  4. Change in Adult Activation

    Change in Pre-/post adult activation using a 5-item assessment adapted from Patient Activation Measure (PAM-10). Higher scores indicate more activation.

    Time frame: Baseline and 3 days later

  5. Proportion of adults who are overdue for each cancer type

    Proportion of adults who are overdue for each cancer type

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • New Brunswick Health Sciences Technology High School
    New Brunswick, New Jersey 08901, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07008781
Lead sponsor
Rutgers, The State University of New Jersey
Responsible party
Sara Heinert, PhD, MPH (Assistant Professor, Rutgers, The State University of New Jersey) — Principal investigator
First posted
Jun 6, 2025
Start date
May 30, 2025
Primary completion
Dec 2026 (estimated)
Completion
Feb 2027 (estimated)
Last update
Apr 28, 2026

Study contacts

Sara Heinert, PhD, MPH
Contact
sara.heinert@rutgers.edu
732-235-7872

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion